DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 213 filers reported holding DENALI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,966,000 | +3.9% | 64,044 | -0.4% | 0.00% | +33.3% |
| Q2 2022 | $1,892,000 | -8.0% | 64,276 | +0.5% | 0.00% | 0.0% |
| Q1 2022 | $2,057,000 | -40.0% | 63,943 | -16.8% | 0.00% | -40.0% |
| Q4 2021 | $3,428,000 | -5.3% | 76,860 | +7.2% | 0.01% | -16.7% |
| Q3 2021 | $3,618,000 | -35.7% | 71,701 | -0.0% | 0.01% | -33.3% |
| Q2 2021 | $5,626,000 | +37.6% | 71,718 | +0.1% | 0.01% | +28.6% |
| Q1 2021 | $4,090,000 | +6.0% | 71,620 | +55.4% | 0.01% | 0.0% |
| Q4 2020 | $3,859,000 | – | 46,082 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |